These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1219676)

  • 21. Fenfluramine in the management of obesity.
    Datey KK; Kelkar PN; Pandya RS
    Br J Clin Pract; 1973 Oct; 27(10):373-5. PubMed ID: 4601613
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical observations on the treatment of obese patients with dexfenfluramine].
    Cairella M; Pisculli M; Petraroli AR; Riganelli S; Saracino A; Siani V
    Clin Ter; 1990 Jun; 133(5):289-97. PubMed ID: 2143712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind cross-over study of fenfluramine (Ponderax) in obesity.
    Rastogi GK; Sharma PL; Saini GS; Kanen VL
    J Assoc Physicians India; 1972 Nov; 20(11):849-52. PubMed ID: 4570012
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diazoxide in the treatment of obesity].
    Marugo M; Giusti M; Cocco R; Bolognesi F; Reitano A
    Boll Soc Ital Biol Sper; 1977 Nov; 53(21):1860-6. PubMed ID: 606277
    [No Abstract]   [Full Text] [Related]  

  • 25. [Influence of fenfluramine on the weekly curve of weight loss during obesity].
    Cabezas Cerrato J; Gómez Pérez M; Marco-Mur AL; Camarero E; Fernández-Cruz A
    Rev Clin Esp; 1974 Jan; 132(1):47-52. PubMed ID: 4840227
    [No Abstract]   [Full Text] [Related]  

  • 26. [Research and experience with fenfluramine in obesity].
    Pawan GS
    Vie Med Can Fr; 1973 May; 2(5):415-22. PubMed ID: 4732200
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparative trial of different regimens of fenfluramine and phentermine in obesity.
    Steel JM; Munro JF; Duncan LJ
    Practitioner; 1973 Aug; 211(262):232-6. PubMed ID: 4580610
    [No Abstract]   [Full Text] [Related]  

  • 28. [Psychological factors in the etiology of obesity and in the long-term treatment of psychiatric obese].
    Gaind R
    Vie Med Can Fr; 1973; 2(2):171-6. PubMed ID: 4706702
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pulmonary hypertension following use of fenfluramine for obesity].
    Maesen BL; Snijder RJ; Stricker BH
    Ned Tijdschr Geneeskd; 1994 Dec; 138(50):2500-2. PubMed ID: 7800076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes in dietary intake of obese patients treated by diet associated with d-fenfluramine].
    Cairella M; Cairella G; Graziani P; Mirante MG; Taghva AR
    Clin Ter; 1992 Mar; 140(3):235-8. PubMed ID: 1568366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter: Fenfluramine approved by F.D.A. in America.
    Parker CH
    Cent Afr J Med; 1974 Mar; 20(3):68-9. PubMed ID: 4825156
    [No Abstract]   [Full Text] [Related]  

  • 32. A double-blind clinical trial of fenfluramine in the treatment of obesity.
    Sainani GS; Fulambarkar AM; Khurana BK
    Br J Clin Pract; 1973 Apr; 27(4):136-8. PubMed ID: 4586636
    [No Abstract]   [Full Text] [Related]  

  • 33. Smoking cessation in a patient being treated with fenfluramine plus phentermine for simple obesity.
    Rothman RB
    J Clin Psychiatry; 1996 Feb; 57(2):92-3. PubMed ID: 8591979
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of fenfluramine, administered on short or long-term basis, on lipolysis of obese subjects].
    Balasse EO
    Vie Med Can Fr; 1973; 2(2):157-62. PubMed ID: 4706699
    [No Abstract]   [Full Text] [Related]  

  • 35. A double-blind clinical trial of fenfluramine.
    Lele RD; Joshi VR; Nathwani AN
    Br J Clin Pract; 1972 Feb; 26(2):79-82. PubMed ID: 4552745
    [No Abstract]   [Full Text] [Related]  

  • 36. Circulatory effects of fenfluramine in obese hypertensive patients.
    Mroczek WJ; Lee WR; Finnerty FA
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1197-202. PubMed ID: 4214654
    [No Abstract]   [Full Text] [Related]  

  • 37. [Psychiatric complications in the treatment of obesity using fenfluramine].
    Klompenhouwer JL; Stricker BH; van Tilburg AJ; Moleman P; Pepplinkhuizen L
    Ned Tijdschr Geneeskd; 1988 Nov; 132(46):2114-7. PubMed ID: 3205320
    [No Abstract]   [Full Text] [Related]  

  • 38. [Glucose tolerance, insulin and lipids in adipose patients following one week of fenfluramine administration].
    Schwandt P; Weisweiler P
    Verh Dtsch Ges Inn Med; 1975; 81():1473-5. PubMed ID: 1227001
    [No Abstract]   [Full Text] [Related]  

  • 39. Dexfenfluramine for obesity.
    Med Lett Drugs Ther; 1996 Jul; 38(979):64-5. PubMed ID: 8692074
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of obesity with fenfluramine (Ponderal)].
    Persson I; Andersen UD; Deckert T
    Ugeskr Laeger; 1973 Sep; 135(36):1932-7. PubMed ID: 4590075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.